Heart Failure
Elamipretide is the research designation for SS-31. Mitochondrial bioenergetics in cardiac tissue models is the focus of research on this compound.

Mitochondrial Function Studies
Free Shipping on orders over $200
Scan the QR code on any vial to verify its batch, COA, and origin in seconds. Secure traceability from our lab to your bench.
SS-31 is also called elamipretide. It is a four amino acid peptide that gathers at the inner membrane of the mitochondria. It does not bind a receptor to get there. Its structure alternates between two kinds of amino acids, and that pattern is what pulls it to the membrane. Studies have measured how it interacts with cardiolipin, a fat found in that membrane, and how the mitochondria perform afterward.
Mitochondria-targeted aromatic-cationic tetrapeptide (cardiolipin-binding)
The pathways SS-31 acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.
SS-31 selectively concentrates in the inner mitochondrial membrane (IMM) where it binds to cardiolipin — a unique phospholipid exclusive to mitochondria. This interaction stabilizes cardiolipin's structure, which is critical for cristae morphology and the assembly of electron transport chain (ETC) supercomplexes.
The dimethyltyrosine (Dmt) residue within SS-31's sequence carries antioxidant capacity concentrated at the site of ROS generation. In preclinical models of ischemia-reperfusion injury, mitochondrial superoxide production and electron transport chain efficiency were measured following SS-31 administration.
Cardiolipin integrity and oxidative damage to ETC complexes are measured alongside the proton gradient across the IMM and ATP synthase function. In aged rodent models, mitochondrial membrane potential and ATP production rates were recorded.
The main areas SS-31 is being studied for — and the study-reported figures behind them.
Elamipretide is the research designation for SS-31. Mitochondrial bioenergetics in cardiac tissue models is the focus of research on this compound.
In rodent models of myocardial and renal ischemia-reperfusion injury, infarct size and organ function markers were measured following SS-31 exposure.
In aged rodents, skeletal muscle mitochondrial function, ATP production rates and physical performance markers were measured following SS-31 administration.
Renal ischemia models are a further area of research interest for SS-31, including kidney injury markers and renal function measures.
An interactive 3D model rendered from the compound record — rotate and explore its structure.
C32H49N9O5
| Also Known As | Elamipretide, MTP-131, Bendavia |
| Sequence | D-Arg-Dmt-Lys-Phe-NH2 |
| Molecular Weight | 638.8 Da |
| Molecular Formula | C32H49N9O5 |
| Target | Cardiolipin / Inner Mitochondrial Membrane |
| Mechanism | Cardiolipin binding; ROS scavenging; ETC stabilization |
| Form | Lyophilized powder (5mg) |
| Purity | ≥99% (HPLC verified) |
| Testing | Third-party HPLC, Mass Spec, Endotoxin |
| Storage | -20°C for long-term stability |
| Solubility | Soluble in water |
| COA | Included with every order |
SS-31 (also known as Elamipretide, MTP-131, or Bendavia) is a synthetic aromatic-cationic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) developed by Hazel Szeto and Peter Schiller, giving it the "SS" designation. Unlike most antioxidants it does not act on ROS systemically — it concentrates selectively at the inner mitochondrial membrane, binding cardiolipin within the architecture of the electron transport chain. That targeting is why it is studied across cardiac, renal and ageing biology.
Cardiolipin is a phospholipid found almost exclusively in the inner mitochondrial membrane. It plays a structural role in organizing the electron transport chain supercomplexes (respirasomes) that drive ATP production. When mitochondria are damaged or aged, cardiolipin becomes oxidized (peroxidized), and cristae disorganization and ETC function are affected. SS-31 binds cardiolipin with high affinity; lower peroxidation and ETC supercomplex assembly are measured alongside, which is the proposed basis for its bioenergetic readouts.
Elamipretide, the research designation for SS-31, is not approved by the FDA or any regulatory agency for any indication. It remains an investigational compound, and this material is supplied exclusively for in vitro laboratory research.
SS-31's uptake into mitochondria is independent of the mitochondrial membrane potential, unlike many other mitochondria-targeted compounds (e.g., MitoQ). This is significant because damaged or depolarized mitochondria — the ones most in need of intervention — can still accumulate SS-31. The peptide's alternating aromatic and cationic residues facilitate spontaneous partitioning into the negatively charged inner mitochondrial membrane.
SS-31 has been studied in: ischemia-reperfusion injury models (cardiac, renal, cerebral); diet-induced and genetic models of heart failure; aged skeletal muscle function studies; models of mitochondrial disease (Barth syndrome); neurodegenerative disease models; and various oxidative stress paradigms. Human clinical data exist for cardiac and renal applications.
Store lyophilized SS-31 at -20°C, protected from light, and minimize freeze-thaw cycles. SS-31 is water-soluble and does not require DMSO for dissolution, which simplifies its handling in aqueous research systems. Always refer to published study protocols for specific concentration and vehicle guidance.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.